The Wrong Blood Type: Jesica Santillan and the Transplant Error That Should Never Have Happened
Jesica Santillan was seventeen years old and had spent most of her life waiting for the moment that arrived on February 7, 2003. Her family had left Guadalajara, Mexico, when she was nine years old, travelling north across the border with the specific purpose of finding care for a congenital heart condition that would kill her without treatment. For eight years, her family had been in the United States seeking this moment: the moment when a compatible heart and lungs became available and the surgery at Duke University Medical Center could proceed.
On the morning of February 7, that moment arrived. Organs were available. The transplant team at Duke assembled. The surgeon, Dr. James Jaggers, performed the operation. When Jesica’s immune system mounted a catastrophic rejection response in the hours afterward, the transplant team eventually understood what had happened: the organs were Type A blood. Jesica was Type O. Someone had failed to verify that the blood types matched before proceeding with the transplant. It was among the most elementary verification steps in organ transplantation. It had not been done.
Jesica survived the first transplant long enough to receive a second, with correctly matched organs, on February 20. She died two days later, on February 22, 2003. She was seventeen years old.
How Jesica Got to Duke
The Santillan family’s journey to Duke University Medical Center was not straightforward. Jesica had hypoplastic left heart syndrome, a severe congenital abnormality in which the left side of the heart is critically underdeveloped. Without surgical intervention, children with this condition do not survive. Even with surgery, the prognosis is often poor, and many patients eventually require heart transplantation.
Her family had limited financial resources and limited legal status in the United States, but they found an advocate in Mack Mahoney, a North Carolina building contractor who had heard about Jesica through a mutual contact and made it his personal mission to help her access the care she needed. Mahoney used his connections and considerable personal persistence to arrange for Jesica to be evaluated at Duke, one of the leading cardiac surgery centres in the country. He raised funds, arranged accommodation, and pushed doors open that the Santillan family could not have opened themselves. By the time Jesica arrived on the transplant waiting list at Duke, she was already a story of extraordinary persistence against formidable odds.
The family had spent approximately ten years and vast resources on her care. They had done everything right. They had found the best hospital, the best surgeon, and the best available system for organ allocation. They had waited.
The Blood Type Mismatch
The ABO blood group system is one of the most fundamental concepts in transfusion medicine and organ transplantation. Blood type determines the presence of certain antigens on the surface of red blood cells and the corresponding antibodies in plasma. When organs from a donor of one blood type are transplanted into a recipient of a different, incompatible type, the recipient’s immune system recognises the donor antigens as foreign and attacks the transplanted organ with an intensity that routine immunosuppression cannot fully control. ABO incompatibility in solid organ transplantation is not a risk to be managed; it is a contraindication, a barrier that must be verified before any organ is accepted for a given patient.
Verification of blood type compatibility between donor and recipient is not a complex test. It is, in fact, one of the most basic elements of organ acceptance. UNOS, the United Network for Organ Sharing, maintains a computerised matching system that is designed to flag incompatibilities before organs are allocated. The system has safeguards. The hospitals receiving and accepting organs have verification protocols of their own. Multiple points in the process exist precisely to catch this kind of error.
All of them failed on February 7, 2003.
The exact sequence of events that resulted in the mismatch was investigated by Duke and by the regulatory authorities that oversee organ transplantation. The most significant failure appears to have occurred when Dr. Jaggers’s team accepted the organs from the organ procurement organisation. The blood type verification, which should have occurred as a matter of course at that stage, did not occur in the way that protocols required. Dr. Jaggers recognised the mismatch and alerted Duke’s transplant programme, but by that point the surgery had already been completed.
The Second Transplant and Jesica’s Death
The decision to attempt a second transplant was medically complex and ethically fraught. Jesica had already suffered severe immune-mediated organ damage. Her brain had been deprived of adequate oxygen. The prognosis was grave, and some physicians involved in her care expressed serious doubts about whether a second transplant could reverse the damage that had already occurred. The decision to proceed was made, and compatible organs became available with unusual speed given the typically long waiting periods on the transplant list.
The second transplant was performed on February 20. On February 22, 2003, Jesica Santillan was declared brain dead. She had been on life support since the second surgery. Her family gathered. The machines were turned off.
The public response to her death was enormous. Her story had been covered in real time by American and international media as the second transplant was arranged, creating a sense among the public that they were watching a family fight for their daughter’s life. When she died, the grief was collective and the anger at the preventable nature of the initial error was palpable. Duke University Medical Center issued a formal apology and acknowledged the error. It paid a confidential financial settlement to the Santillan family. Duke also committed to reviewing and strengthening its transplant verification protocols.
The Preventability and Its Meaning
In the taxonomy of medical error, the Jesica Santillan case is classified by patient safety researchers as an example of a “never event”: a category of serious preventable adverse events that healthcare institutions are expected to have systems specifically designed to prevent from ever occurring. Blood type mismatch in solid organ transplantation is definitionally a never event; the verification systems that exist across the organ procurement and transplantation network are meant to make it impossible.
The fact that all those systems failed simultaneously is not evidence that the systems were fundamentally unsound. It is evidence of what human factors researchers call “system failure,” where a chain of individually small deviations from protocol compounds into a catastrophic outcome. At no single point in the chain did one person make a decision knowing it would lead to Jesica’s death. At each point, a step was missed or a verification was skipped or a question was not asked because the person responsible assumed that someone else had already asked it. The result was the same as if the error had been deliberate.
This is the nature of the harm that medical systems are designed to prevent and that systems failures produce. Medical malpractice law in the civil context is designed to compensate individual victims and to create financial incentives for institutions to maintain adequate safety systems. The confidential settlement Duke paid the Santillan family is the civil law’s response. It does not identify what went wrong in the specific chain of decisions and omissions. It does not produce the kind of public detailed account that might prevent the next error of this kind. It resolves a financial liability.
The regulatory and quality improvement response, through the investigation of the incident by the Organ Procurement and Transplantation Network and by Duke’s own quality improvement processes, is the mechanism through which the specific failures are identified and the specific protocols strengthened. Those processes produced changes to verification requirements in Duke’s transplant programme and contributed to national discussions about how the redundant safeguards in the organ transplantation system could be made more robust. The changes came too late for Jesica Santillan and her family, who had given everything to reach a moment that the system then failed to handle correctly.
TL;DR: Key Facts, Legal Concepts, and Why This Case Matters
Who was Jesica Santillan?
Jesica Santillan (April 26, 1985 to February 22, 2003) was a seventeen-year-old Mexican immigrant who had lived in the United States since age nine, where her family sought treatment for hypoplastic left heart syndrome. On February 7, 2003, she received a heart-lung transplant at Duke University Medical Center with organs that were blood type A, despite being type O herself. The immune rejection caused severe organ damage and brain injury. A second transplant on February 20 with compatible organs failed to reverse the damage. She died on February 22, 2003.
How did the blood type mismatch occur?
The blood type mismatch in the Santillan case resulted from a failure in the organ acceptance verification process. Verification of ABO blood type compatibility between donor and recipient is a required step in organ transplantation and one of the most basic safety checks in the process. The verification failed at the Duke end of the process when Dr. Jaggers’s team accepted the organs. Multiple safeguards designed to catch exactly this error all failed to operate as intended. Dr. Jaggers recognised the error and disclosed it immediately, but by that point the transplant had been completed.
What is a “never event” in patient safety?
A “never event” is a serious preventable adverse occurrence in healthcare that is so clearly and fundamentally preventable that healthcare institutions are expected to have systems that would prevent it from ever occurring. The category was developed by the National Quality Forum in the United States as a framework for identifying harms that should not happen at all, rather than adverse events that represent acceptable risk. Blood type mismatch in solid organ transplantation is one of the most widely cited examples of a never event because the verification systems across the organ procurement and transplantation network exist specifically to make it impossible. When a never event occurs, it signals a failure not just of individual performance but of the entire system of safeguards.
What were the legal and institutional consequences?
Duke University Medical Center publicly acknowledged the error, apologised to the Santillan family, and paid a confidential financial settlement. The case was reviewed by the Organ Procurement and Transplantation Network (OPTN), the body that oversees organ matching and allocation in the United States. Duke reviewed and strengthened its transplant verification protocols. No criminal charges were filed against any individual involved in the transplant. The settlement amount was not publicly disclosed.
Was Dr. Jaggers disciplined?
Dr. James Jaggers, the transplant surgeon who performed the operation, disclosed the error himself when he recognised it during the surgery. He cooperated fully with the investigation. The public record does not reflect that he was criminally charged or that his medical licence was suspended. The case was handled primarily through civil settlement and institutional quality improvement processes rather than through individual criminal or professional discipline. The nature of the error, a verification failure at the system level rather than a deliberate act, placed it within the framework of institutional accountability rather than individual criminal culpability.
What did this case change?
The Santillan case contributed to national attention on the verification processes in organ transplantation and to efforts to strengthen the redundant safeguards designed to prevent blood type mismatches. It also became a reference point in discussions about the role of social advocacy in gaining access to transplant care, and in debates about immigration policy and access to healthcare for undocumented patients. More broadly, it became a touchstone case in medical education and patient safety training for its illustration of how a chain of small system failures can produce a catastrophic outcome that no single individual intended.
